Dimerix needed to put that ASX Ann out this morning. From the...

Dimerix needed to put that ASX Ann out this morning. From the ANN:

“DMX-200 has enormous potential to improve patient outcomes and is preparing to take DMX-200 into further trials. The company however notes that it has not provided definitive guidance on timing to bring DMX-200 to market, despite the news segment stating this could potentially be on market within the next two years.”

I do believe that Dimerix did not provide that information to Channel 7 (timeframe) & their phones must have been running hot this morning with patients enquiring. That timeframe indication must have come from somewhere? I know the media gets it wrong at times, but surely they couldn’t just pull a figure out of a hat? It was news to me last night too, so you would think that would have been price sensitive information, on market within 2 years. Who needs a Pharma Deal lol?

If 2b is as successful as 2a with safety & efficacy, I don’t see it being out of the question as a massively unmet global heath need. I hope Kathy didn’t have a headache today.